List of Minocin drug patents

Minocin is owned by Rempex.

Minocin contains Minocycline Hydrochloride.

Minocin has a total of 2 drug patents out of which 0 drug patents have expired.

Minocin is available in injectable;injection dosage forms.

Minocin can be used as method of treating bacterial infections.

The generics of Minocin are possible to be released after 12 May, 2031.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9084802 REMPEX Tetracycline compositions
May, 2031

(8 years from now)

US9278105 REMPEX Tetracycline compositions
May, 2031

(8 years from now)

Drugs and Companies using MINOCYCLINE HYDROCHLORIDE ingredient

Treatment: Method of treating bacterial infections

Dosage: INJECTABLE;INJECTION

How can I launch a generic of MINOCIN before it's patent expiration?
More Information on Dosage

MINOCIN family patents

8

United States

2

Spain

2

Japan

2

New Zealand

2

European Union

1

Israel

1

South Africa

1

Denmark

1

Mexico

1

Australia

1

Hong Kong

1

Russia

1

Hungary

1

Singapore

1

Colombia

1

Brazil

1

Portugal

1

Korea, Republic of

1

Poland

1

Chile

1

China

1

Canada

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in